pharmaceutical preparations for treatment of pain, allergies, insomnia, heartburn, high-blood pressure, coughing, fever, colds, diarrhea, constipation, all of the foregoing using dosage forms to make medicines easier to take, manage and monitor; pharmaceutical preparations, namely, unit does capsules sold empty using dosage forms to make medicines easier to take, manage and monitor; pharmaceutical preparations for the treatment of infectious d...
On Tuesday, July 3, 2018,
a U.S. federal trademark registration was filed for
MADRONA PHARMACEUTICALS.
The USPTO has given the MADRONA PHARMACEUTICALS
trademark serial number of 88025130.
The current federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE.
The correspondent listed for MADRONA PHARMACEUTICALS is
MATTHEW MOERSFELDER of
DAVIS WRIGHT TREMAINE LLP, 920 Fifth Avenue, Suite 3300, SEATTLE WA 98104-1610
.
The MADRONA PHARMACEUTICALS trademark is filed in the category of
Pharmaceutical Products
.
The description provided to the USPTO for MADRONA PHARMACEUTICALS
is pharmaceutical preparations for treatment of pain, allergies, insomnia, heartburn, high-blood pressure, coughing, fever, colds, diarrhea, constipation, all of the foregoing using dosage forms to make medicines easier to take, manage and monitor; pharmaceutical preparations, namely, unit does capsules sold empty using dosage forms to make medicines easier to take, manage and monitor; pharmaceutical preparations for the treatment of infectious diseases caused by Bacillus anthracis, Bacillus cereus, Bartonella henselae, Bartonella Quintana, Bordetella pertussis, Borrelia burgdorferi, Borrelia garinii, Borrelia afzelii, Borrelia recurrentis, Brucella abortus, Brucella canis, Brucella melitensis, Brucella suis, Campylobacter jejuni, Chlamydia pneumoniae, Chlamydia trachomatis, Chlamydophila psittaci, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Clostridium tetani, Corynebacterium diphtheriae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Francisella tularensis, Haemophilus influenzae, Helicobacter pylori, Legionella pneumophila, Leptospira interrogans, Leptospira santarosai, Leptospira weilii, Leptospira noguchii, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Mycobacterium ulcerans, Mycoplasma pneumoniae, Neisseria gonorrhoeae, Neisseria meningitidis, Pseudomonas aeruginosa, Rickettsia rickettsia, Salmonella typhimurium, Shigella sonnei, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus saprophyticus, Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, Treponema pallidum, Ureaplasma urealyticum, Vibrio cholerae, Yersinia pestis, Yersinia enterocolitica, or Yersinia pseudotuberculosis using dosage forms to make medicines easier to take, manage and monitor.
Classification Information
Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.
| Primary Class: |
Class Details: |
| Class (005) |
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided
|